Janumet-XR-Cp Kit 7 Tablets

babies: not applicable. lactating mothers: it is usually safe to use during breastfeeding.
consult your doctor before use. pregnancy: it is usually safe to use during pregnancy.
consult your doctor before use. driving: metformin hcl, sitagliptin affects the ability to drive.
do not drive if any symptoms occur. alcohol: avoid consumption of alcohol while taking this tablet as it may lead to lactic acidosis.
seek a doctor’s advice before using this medication. kidney: metformin hcl, sitagliptin should be used with caution in patients suffering from kidney disease.
you may require dosage adjustment. seek a doctor’s advice before using this medication.
liver: metformin hcl, sitagliptin should be used with caution in patients suffering from liver disease. you may require dosage adjustment.
seek a doctor’s advice before using this medication. .

Nausea Indigestion Constipation Dizziness Excessive sweating Chills Skin rash Redness of face and neck Palpitation Throat irritation Weight Gain Headache Vomiting Diarrhoea Abdominal pain .

JANUMET-XR-CP is a combinational dpp4 inhibitor and biguanides, an antidiabetic agent, helps to sensitize insulin & control sugar levels. both medications help to prevent high blood glucose levels after having food..

If you miss a dose of JANUMET-XR-CP take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

•JANUMET-XR-CPneeds to be taken regularly to control blood sugar levels. • exercise regularly for a better outcome • maintaining a healthy lifestyle is essential.
• alcohol consumption needs to be avoided while on this medication. • check your blood sugar level regularly.
• avoid junk and oily foods. • stress should be avoided to keep your sugar levels under control.
• to reduces the risk of heart diseases, you should check blood pressure regularly..

•metformin hcl, sitagliptin + levothyroxine: concurrent use leads to interfere with blood glucose levels and reduce the efficacy of metformin. •metformin hcl, sitagliptin + insulin glargine: concurrent use with insulin glargine can increase the risk of hypoglycemia.
.